TY  - JOUR

T1  - Osilodrostat dose impact on efficacy/safety in Cushing's disease: large, pooled analysis of LINC 2, 3, and 4

JO  - European Journal of Endocrinology

UR  - https://doi.org/10.1093/ejendo/lvaf207

PY  - 2025/10/06

AU  - Fleseriu M

AU  - Pivonello R

AU  - Lacroix A

AU  - Biller BMK

AU  - Feelders R

AU  - Gadelha M

AU  - Bertherat J

AU  - Belaya Z

AU  - Piacentini A

AU  - Pedroncelli AM

AU  - Newell-Price J

ED  - 

DO  - DOI: 10.1093/ejendo/lvaf207

PB  - Oxford University Press (OUP)

VL  - 193

IS  - 5

SP  - 606

EP  - 617

Y2  - 2025/11/05

ER  -